AUA 2024: Association between Enfortumab-Vedotin Related Cutaneous Reaction and Serum Albumin Levels in Patients with Advanced Urothelial Cancer
AUA 2024, Advanced Urothelial Cancer, bladder cancer, Enfortumab Vedotin (EV), Enfortumab Vedotin Related Cutaneous Reaction, Serum Albumin Levels, th Enfortumab Vedotin and its relationship with serum albumin levels, nectin-4, avelumab, pembrolizumab, Enfortumab Vedotin in Japan.